- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
Posterior Urethral Valve |
19 |
|
19.1Introduction
•Posterior urethral valve (PUV) disorder is an obstructive developmental anomaly of the male urethra.
•It is characterized by a congenital membrane obstructing the posterior male urethra.
•As a result of urinary obstruction, there is a backward pressure and reverse urinary flow which can affect the urethra, bladder, ureters, and kidneys (Fig. 19.1).
•Hugh Hampton Young published the first description of posterior urethral valves (PUVs) in 1919.
•PUVs occur exclusively in males. The homolog to the male verumontanum from which the valves originate is the female hymen.
•It is considered the most common cause of bladder outlet obstruction in male newborns.
•The incidence of posterior urethra is 1 in 5,000–8,000 live male newborns.
•The valve is believed to result from abnormal embryologic development of the fetal posterior urethra.
•PUV mechanically obstruct normal bladder emptying and increases voiding pressures.
•The disorder varies in degree of obstruction from mild to severe incompatible with postnatal life.
•Severe posterior urethral valves are known to be associated with renal and respiratory failure from lung underdevelopment as result of low amniotic fluid volumes.
•An increasing number of cases are diagnosed antenatally.
•Patients with PUVs have a higher incidence of cryptorchidism when compared to normal patients.
•Other known associated anomalies include VATER or VACTERL and rarely ano-rectal malformation.
•Prenatal intervention in those with PUV does not appear to confer a benefit in the long-term outcome of renal function.
•Primary valve ablation is the recommended treatment of choice with diversion being reserved for specific individual cases.
•The most life-threatening problem in the newborn period is the potential pulmonary hypoplasia related to in utero oligohydramnios and renal dysfunction. These patients may present with pneumothoraces at birth which will complicate their pulmonary management.
•Newborns are also susceptible to urosepsis as a result of urinary stasis.
•The presentation of PUV is variable depending on the degree of obstruction and the spectrum of renal dysfunction and subsequent functional outcomes also vary widely.
•A significant number of boys with PUV will develop chronic kidney disease and end stage renal failure.
•This is attributed to its consequences, including:
–Renal dysplasia
–Upper urinary tract dilatation
© Springer International Publishing Switzerland 2017 |
423 |
A.H. Al-Salem, An Illustrated Guide to Pediatric Urology, DOI 10.1007/978-3-319-44182-5_19 |
|
424 |
19 Posterior Urethral Valve |
|
|
Fig. 19.1 A voiding cystourethrogram showing posterior urethral valve. Note the dilated posterior urethra with the valve, the associated bladder diverticulum and right side vesicoureteric reflux
VESICOURETERIC
REFLUX
ANTERIOR
URETHRA
URINARY
BLADDER
BLADDER
DIVERTICULUM
POSERIOR URETHRA WITH VALVE
–Vesico-ureteric reflux
–Urinary tract infection
–Bladder dysfunction
•PUV accounts for 25–30 % of pediatric renal transplantations.
•The VURD (valves unilateral reflux dysplasia) syndrome:
–This was described by Hoover and Duckett.
–It results in very poor or non-function of the kidney on the refluxing side with a relative sparing of renal function on the contralateral, non-refluxing side.
–The authors also postulated that this mechanism of ‘pop-off’ results in long-term normal renal function, as the contralateral kidney is spared and normal.
–This hypothesis was subsequently challenged by Cuckow et al. who showed with serum creatinine and GFR measurements that renal function was impaired in cases with VURD, implying that the protection offered by the ‘pop-off’ mechanism was not complete
19.2Embryology
•Embryologically, the most caudal end of the Wolffian duct is absorbed into the primitive cloaca at the site of the future verumontanum in the posterior urethra.
•In healthy males, the remnants of this process are the posterior urethral folds, called plicae colliculi.
•The embryological abnormality giving rise to posterior urethral valves is not well known.
•It has been suggested that posterior urethral valves result from fusion of the plicae colliculi (posterior urethral folds) between the entrances of the seminal vesicles at the veromontanum, and extend to the membranous urethra.
•PUVs are formed at approximately 4 weeks’ gestation, as the Wolffian duct fuses with the developing cloaca.
•There are several theories explaining the embryological origin of PUVs:
–PUVs may represent an anomalous insertion of the mesonephric duct into the
19.3 |
Pathophysiology |
|
|
|
|
|
|
|
425 |
|
|
|
|||||||
|
uro-genital sinus, preventing normal |
– Hypertrophy and hyperplasia of the detru- |
|||||||
|
migration of these ducts and their anterior |
|
sor muscle of the urinary bladder and |
||||||
|
fusion. |
|
|
|
|
increases in connective tissue limit bladder |
|||
– PUVs may represent an abnormality of the |
|
compliance during filling. |
|
||||||
|
cloacal membrane. |
|
|
|
– As a result of this, bladder emptying occurs |
||||
• Early classification of PUV was done by Hugh |
|
at high intravesical pressures. |
|
||||||
Hampton Young in 1919, who described three |
– This high intravesical pressure, in turn, can |
||||||||
types of PUVs, I–III based on post-mortem |
|
be transmitted to the ureters and up into the |
|||||||
dissection studies. |
|
|
|
|
renal collecting system and kidneys. |
||||
• Subsequently, Dewan et al. suggested a more |
– The end result of this is increased suscepti- |
||||||||
uniform and similar appearance to the |
|
bility to incontinence, infection, and pro- |
|||||||
obstructing posterior urethral membrane. |
|
gressive renal damage. |
|
|
|||||
• Their endoscopic appraisal revealed the mem- |
– The bladder dysfunction may cause ongo- |
||||||||
brane to attach posteriorly, just distal to the |
|
ing and progressive renal deterioration. |
|||||||
verumontanum. The |
membrane |
extended |
– |
Renal insufficiency is caused by PUVs in |
|||||
anteriorly and obliquely beyond the external |
|
approximately 10–15 % of children under- |
|||||||
sphincter with a variable sized aperture located |
|
going renal transplantation, and approxi- |
|||||||
within it, at the level of the verumontanum. |
|
mately one third of patients born with PUVs |
|||||||
• They described the membrane as congenital |
|
progress to end-stage renal disease (ESRD). |
|||||||
obstructing posterior |
urethral |
membrane |
• PUVs lead to mechanical obstruction which |
||||||
(COPUM). |
|
|
|
affect normal bladder emptying and this will |
|||||
• Congenital obstructing posterior urethral |
lead to: |
|
|
||||||
membrane (COPUM) was first proposed by |
– |
High intraluminal pressure |
|
||||||
Dewan and Goh and was later supported by |
– |
Increases voiding pressures |
|
||||||
histological studies by Baskin. |
|
|
– Maldevelopment of the |
kidneys, |
ureters |
||||
• This concept proposes that, instead of a true |
|
and urinary bladder |
|
|
|||||
valve, a persistent oblique membrane is rup- |
– |
Renal maldevelopment: |
|
|
|||||
tured by initial catheter placement and, sec- |
|
• |
Renal parenchymal dysplasia is com- |
||||||
ondary to rupture, forms a valve like |
|
|
mon and may be related to maldevelop- |
||||||
configuration. |
|
|
|
|
|
ment of the metanephric blastema |
|||
|
|
|
|
|
|
• Renal tubular function may be affected |
|||
|
|
|
|
|
|
|
by high pressures that result in poor uri- |
||
19.3 |
Pathophysiology |
|
|
|
|
||||
|
|
|
|
nary concentrating ability |
|
||||
|
|
|
|
|
|
• Diuresis secondary |
to high |
urinary |
|
• Posterior urethral valve is known to be asso- |
|
|
production |
|
|
||||
ciated with significant morbidity which is |
|
• This high urinary production will lead |
|||||||
not merely limited to transient urethral |
|
|
to ureteral and bladder dysfunction |
||||||
obstruction. |
|
|
|
– Renal deterioration may also occur due to |
|||||
• The congenital obstruction of the urinary tract |
|
hyperfiltration injury that causes: |
|
||||||
at a critical time in organogenesis may pro- |
|
• |
Glomerulosclerosis |
|
|
||||
foundly affect lifelong kidney, ureteral, and |
|
• Chronic pyelonephritis associated with |
|||||||
bladder function as follows: |
|
|
|
|
vesicoureteral reflux |
|
|
||
– Outflow obstruction leads to increased col- |
|
• |
Urinary stasis |
|
|
||||
|
lagen deposition and muscle hypertrophy |
|
• |
Incomplete bladder emptying |
|
||||
|
of the urinary bladder which can signifi- |
– |
These will also cause further insult to the |
||||||
|
cantly thicken the bladder wall. |
|
|
|
developing kidneys. |
|
|
426 |
19 Posterior Urethral Valve |
|
|
•Hydronephrosis is common in these patients for several reasons:
–Bladder dysfunction with high back pressures on the ureter.
–An abnormally deficient musculature of the ureter due to chronic distention from high pressure or high urine flow.
–High urinary flow due to the lack of urinary concentrating ability of the nephron can dilate the kidneys and ureters.
–Abnormalities of the vesicoureteral junction, such as reflux or, rarely, ureterovesical obstruction.
•Vesicoureteral reflux is present in one half of male patients with a posterior urethral valve for the following reasons:
–Secondary to increased intravesical pressure which overcomes the competence of the ureterovesical junction.
–Secondary to abnormal ureteral orifice position resulting from abnormal ureteral bud development during embryogenesis.
•Bladder dysfunction in patients with PUV is secondary to:
–Alterations in collagen deposition.
–Alteration in the development of detrusor smooth muscle cells.
–Poor compliance or uninhibited contraction of the detrusor muscle and eventual myogenic failure.
–In mild cases, incontinence may be present.
–In severe cases, ongoing deterioration of renal function occurs.
–Bladder dysfunction often improves over time after definitive treatment of the obstruction.
–Persistence of bladder dysfunction increases the risk of:
•Urinary tract infection
•Persistent hydronephrosis
•Vesicoureteral reflux
•Incontinence
–All of these diminish renal function further.
•Several protective mechanisms may develop in boys with a posterior urethral valve; these may lower intraluminal pressures and allow at least one renal unit to develop more
normally. These protective mechanisms include:
–Massive unilateral vesicoureteral reflux.
–This is usually associated with an ipsilateral dysplastic kidney, known as vesicoureteral reflux and dysplasia syndrome.
–Development of bladder diverticula.
–Rupture of renal calyces and development of urinary ascites.
•As patients with PUV age, bladder decompensation may develop, resulting in detrusor failure and increased bladder capacity.
•Many boys with PUV as they grow older will develop larger-than-expected bladder volumes possibly due to overproduction of urine caused by tubular dysfunction and an inability to concentrate urine (nephrogenic diabetes insipidus).
•Bladder function may change at puberty, resulting in high-pressure, chronic retention and necessitating the need for lifelong bladder management.
•Symptoms of bladder dysfunction may persist into adulthood in up to one third of patients and include urinary incontinence in up to 15 % of adults with a history of PUV.
19.4Classification
•A PUV is a congenital obstruction caused by an embryological malformation of the posterior urethra.
•Posterior urethral valves are usually fusion of the plicae colliculi between the entrances of the seminal vesicles at the veromontanum, and extend to the membranous urethra.
•The verumontanum, or mountain ridge, is a distinctive landmark in the prostatic urethra and it is important in the classification of posterior valves.
•This malformation will result in urethral obstruction.
•The significance of this obstruction depends on the secondary effects on:
–The urinary bladder
–The ureters
–The kidneys